A large clinical trial suggests that a personalized mRNA vaccine combined with the immunotherapy drug Keytruda may help prevent melanoma from returning after surgery.
Personalized mRNA vaccine shows promise in preventing melanoma recurrence
A large clinical trial suggests that a personalized mRNA vaccine combined with the immunotherapy drug Keytruda may help prevent melanoma from returning after surgery.
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.